NCT06408584View on ClinicalTrials.gov

Short-course Hypofractionated Radiotherapy in Combination With Raltitrexed and Tislelizumab

RecruitingOBSERVATIONAL

Enrollment

25

Participants

Timeline

Start Date

March 1, 2024

Primary Completion Date

March 1, 2027

Study Completion Date

March 1, 2027

Conditions

Esophageal Squamous Cell Carcinoma

Trial Locations (1)

230001

RECRUITING

Yuan He, Hefei

All Listed Sponsors

lead

Anhui Provincial Hospital

OTHER_GOV